Xtant Medical Holdings, Inc. (XTNT): Price and Financial Metrics

Xtant Medical Holdings, Inc. (XTNT): $1.10

0.06 (-5.17%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

XTNT Price/Volume Stats

Current price $1.10 52-week high $1.45
Prev. close $1.16 52-week low $0.56
Day low $1.05 Volume 105,300
Day high $1.16 Avg. volume 95,853
50-day MA $1.09 Dividend yield N/A
200-day MA $1.08 Market Cap 143.12M

XTNT Stock Price Chart Interactive Chart >

XTNT POWR Grades

  • XTNT scores best on the Sentiment dimension, with a Sentiment rank ahead of 97.59% of US stocks.
  • The strongest trend for XTNT is in Sentiment, which has been heading up over the past 42 days.
  • XTNT ranks lowest in Quality; there it ranks in the 11th percentile.

XTNT Stock Summary

  • With a year-over-year growth in debt of 59.09%, XTANT MEDICAL HOLDINGS INC's debt growth rate surpasses 88.03% of about US stocks.
  • Over the past twelve months, XTNT has reported earnings growth of -144.9%, putting it ahead of merely 9.46% of US stocks in our set.
  • As for revenue growth, note that XTNT's revenue has grown 38.46% over the past 12 months; that beats the revenue growth of 88.01% of US companies in our set.
  • Stocks that are quantitatively similar to XTNT, based on their financial statements, market capitalization, and price volatility, are AVD, HNI, HURC, ELMD, and SITE.
  • Visit XTNT's SEC page to see the company's official filings. To visit the company's web site, go to www.xtantmedical.com.

XTNT Valuation Summary

  • XTNT's price/sales ratio is 1.9; this is 13.64% lower than that of the median Healthcare stock.
  • Over the past 164 months, XTNT's price/sales ratio has gone down 24.8.

Below are key valuation metrics over time for XTNT.

Stock Date P/S P/B P/E EV/EBIT
XTNT 2023-12-29 1.9 2.7 53.4 51.7
XTNT 2023-12-28 2.0 2.9 56.7 54.7
XTNT 2023-12-27 2.0 2.9 56.7 54.7
XTNT 2023-12-26 2.0 2.9 57.2 55.1
XTNT 2023-12-22 2.0 2.9 57.6 55.5
XTNT 2023-12-21 1.9 2.7 53.8 52.2

XTNT Growth Metrics

    Its 4 year price growth rate is now at -88.13%.
  • The 5 year price growth rate now stands at -88.13%.
  • The 3 year revenue growth rate now stands at -21.57%.
XTNT's revenue has moved down $8,014,000 over the prior 33 months.

The table below shows XTNT's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 56.668 -2.63 -8.559
2022-06-30 55.983 -1.492 -8.01
2022-03-31 55.681 0.742 -7.033
2021-12-31 55.263 0.439 -4.849
2021-09-30 55.309 0.932 -3.272
2021-06-30 55.548 1.787 -2.828

Xtant Medical Holdings, Inc. (XTNT) Company Bio


Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and devices in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS for use as a bone void filler and bone graft substitute in the pelvis, extremities, and posterolateral spine; and OsteoWrap that wraps around non-union fractures to assist with fusion, as well as could be used in conjunction with a hardware plate system. The company is based in Montana.


XTNT Latest News Stream


Event/Time News Detail
Loading, please wait...

XTNT Latest Social Stream


Loading social stream, please wait...

View Full XTNT Social Stream

Latest XTNT News From Around the Web

Below are the latest news stories about XTANT MEDICAL HOLDINGS INC that investors may wish to consider to help them evaluate XTNT as an investment opportunity.

Q3 2023 Xtant Medical Holdings Inc Earnings Call

Q3 2023 Xtant Medical Holdings Inc Earnings Call

Yahoo | November 10, 2023

Xtant Medical to Participate in Upcoming Investor Conferences

BELGRADE, Mont., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that management will participate in two upcoming investor conferences: Jefferies London Healthcare Conference – November 14-16 Sean Browne, President and CEO, will present on Thursday, November 16 at 11:00 AM GMT / 6:00 AM ET and participate in 1x1 meetings with institutional

Yahoo | November 9, 2023

Xtant Medical Holdings Inc (XTNT) Reports Record Q3 Revenue and Raises 2023 Guidance

XTNT Achieves 73% Year-Over-Year Revenue Growth in Q3; Net Income Reaches $9.2 Million

Yahoo | November 9, 2023

Xtant Medical Announces Record Third Quarter Revenue of $25 Million

Raises 2023 Annual Revenue Guidance to $88 Million - $91 MillionBELGRADE, Mont., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the third quarter ended September 30, 2023. “Driven by strong organic growth of 18%, and contributions from our recent acquisitions, we achieved record third quarter revenue of

Yahoo | November 9, 2023

Xtant Medical to Issue Third Quarter 2023 Financial Results on November 9, 2023

BELGRADE, Mont., Nov. 02, 2023 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that it will release its financial results for the third quarter ended September 30, 2023, before the open of the financial markets on Thursday, November 9, 2023. Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will host a confere

Yahoo | November 2, 2023

Read More 'XTNT' Stories Here

XTNT Price Returns

1-mo 3.77%
3-mo -2.65%
6-mo -3.51%
1-year 43.42%
3-year -63.09%
5-year -64.63%
YTD -2.65%
2023 71.21%
2022 17.86%
2021 -53.18%
2020 -25.24%
2019 -0.62%

Continue Researching XTNT

Want to see what other sources are saying about Xtant Medical Holdings Inc's financials and stock price? Try the links below:

Xtant Medical Holdings Inc (XTNT) Stock Price | Nasdaq
Xtant Medical Holdings Inc (XTNT) Stock Quote, History and News - Yahoo Finance
Xtant Medical Holdings Inc (XTNT) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!